Elevation Oncology Inc. (NASDAQ: ELEV) Stock Information | RedChip

Elevation Oncology Inc. (NASDAQ: ELEV)


$0.5646
-0.0089 ( -2.66% ) 433.0K

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Market Data


Open


$0.5646

Previous close


$0.5735

Volume


433.0K

Market cap


$33.67M

Day range


$0.5500 - $0.5930

52 week range


$0.4401 - $5.8299

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 2 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 14 Jun 14, 2024
4 Insider transactions 1 May 17, 2024
8-k 8K-related 16 May 02, 2024
10-q Quarterly Reports 79 May 02, 2024

Latest News